Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically‐obese db/db mice
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Aim: AMPK activates SIRT1 in liver and skeletal muscle. Impaired circadian function is associated with development of obesity. SIRT1 regulates circadian function and is suppressed in white adipose tissue (WAT) of obese patients. We examined the potential role of AMPK and SIRT1 in regulation of circadian components in WAT of obese db/db mice and in mice fed a high‐fat diet (HFD), and investigated whether metformin‐mediated activation of AMPK opposed any deleterious changes in the WAT clock mechanism. Methods: db/ + and db/db mice were administered metformin (250 mg/kg/day; 7 days). Separately, mice were fed HFD for 16‐weeks. 3T3‐L1 adipocytes were incubated with metformin, EX527 or FK866, inhibitors of SIRT1 and NAMPT, respectively. Gene and protein expression were measured by qRT‐PCR and immunoblotting. Results: AMPK activity, NAMPT expression and SIRT1 expression were decreased in WAT of db/db and HFD mice, in association with suppressed expression of the core circadian components CLOCK and BMAL1. Expression of Pparγ and the adipogenic repressors Irf3 and Irf4 were also suppressed. Metformin increased AMPK activity in WAT of db/db mice and in metformin‐treated adipocytes, with increased NAMPT, SIRT1 and circadian component expression. Metformin‐mediated induction of Clock mRNA in adipocytes was blocked by inhibition of NAMPT and SIRT1. Conclusions: Decreased AMPK‐SIRT1 signalling in db/db and HFD mice impacts WAT circadian function causing dysregulated lipid regulation, favouring an obese phenotype. Metformin mediates a phenotypic shift away from lipid accretion through AMPK‐NAMPT‐SIRT1 mediated changes in clock components, supporting chronotherapeutic treatment approaches for obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
Turek, F. W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D. R., et al. (2005) · Science · doi:10.1126/science.1108750 · Cited by 2,485 · cited 2×
“Gene expression of SIRT1 is suppressed in WAT of obese and insulin-resistant subjects [4,5] and epidemiological and experimental evidence suggests that dysregulation of circadian function could underlie the development of obesity and insulin resistance [7,8,23].”
BackgroundNakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P., & Sassone-Corsi, P. (2008) · Cell · doi:10.1016/j.cell.2008.07.002 · Cited by 1,427 · cited 1×
“Recently, SIRT1 has been identified as a key post-translational regulator of clock proteins [11,12], in particular gene expression of Clock, Bmal1, Per2 and Cry1 were all suppressed in SIRT1−/− mouse embryonic fibroblasts [12].”
BackgroundAdiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Karlsson, B., Knutsson, A., & Lindahl, B. (2001) · Occupational and Environmental Medicine · doi:10.1136/oem.58.11.747 · Cited by 924 · cited 2×
“Gene expression of SIRT1 is suppressed in WAT of obese and insulin-resistant subjects [4,5] and epidemiological and experimental evidence suggests that dysregulation of circadian function could underlie the development of obesity and insulin resistance [7,8,23].”
BackgroundVillaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M.-A., Sengenès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., et al. (2010) · Diabetes · doi:10.2337/db10-0398 · Cited by 282 · cited 6×
“PPARγ is essential for induction of adipogenic genes.”
BackgroundInfluentialUm, J. H., Yang, S., Yamazaki, S., Kang, H., Viollet, B., Foretz, M., & Chung, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700070200 · Cited by 244
Bray, M. S., & Young, M. E. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00277.x · Cited by 213
When the Clock stops ticking, metabolic syndrome explodes
Staels, B. (2006) · Nature Medicine · doi:10.1038/nm0106-54 · Cited by 167 · cited 5×
“PPARγ is essential for induction of adipogenic genes.”
BackgroundInfluentialSIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity
Rutanen, J., Yaluri, N., Modi, S., Pihlajamäki, J., Vänttinen, M., Itkonen, P., Kainulainen, S., Yamamoto, H., Lagouge, M., Sinclair, D. A., et al. (2010) · Diabetes · doi:10.2337/db09-1191 · Cited by 104 · cited 2×
“SIRT1 represses adipogenesis in white adipose tissue (WAT) through suppressed expression of peroxisome-proliferator activated receptor (PPAR) γ [3,4], whilst SIRT1 gene expression is suppressed in WAT of obese and insulin-resistant patients [4,5].”
Background
Cited by
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
“However, in animal models, metformin mediates a phenotypic shift away from lipid accretion through AMP-activated Protein Kinase-Nicotinamide phosphoribosyltransferase-Sirtuin 1-mediated changes in metabolism supporting treatment for obesity (64).”
BackgroundRole of AMP-activated protein kinase in adipose tissue metabolism and inflammation
Bijland, S., Mancini, S. J., & Salt, I. P. (2013) · Clinical Science · doi:10.1042/cs20120536 · Cited by 284
Effects of metformin on weight loss: potential mechanisms
Malin, S. K., & Kashyap, S. R. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000095 · Cited by 223
“In obese db/db mice and high-fat fed mice, metformin increased the expression of adipose-derived circadian locomotor output cycles kaput (CLOCK), brain and muscle aryl hydrocarbon receptor nuclear translocator-line 1 (BMAL1), and period (PER) 2 through AMPK activation, which were paralleled by improvements in insulin…”
BackgroundStromsdorfer, K. L., Yamaguchi, S., Yoon, M. J., Moseley, A. C., Franczyk, M. P., Kelly, S. C., Qi, N., Imai, S.-I., & Yoshino, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.027 · Cited by 213
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
“Increased SIRT1 and AMPK activity inhibits dysregulation of lipids and obese phenotypes [171].”
Metadata
- Authors
- Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2011-10-27
- Volume
- 13
- Issue
- 12
- Pages
- 1097-1104
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2062360005
- Cited by
- 101
- References
- 9
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically‐obese db/db mice. https://app.cochat.ai/papers/10.1111/j.1463-1326.2011.01466.x
- The paper
- Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011). Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically‐obese db/db mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2011.01466.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.